Biocryst Pharmaceuticals Inc (BCRX)

06:16 AM

Orbimed Advisors LLC Sells 316,600 Shares of BioCryst Pharmaceuticals, Inc. $BCRX - MarketBeat

06:16 AM

03:21 AM

BioCryst Pharma Market Sentiment - Benzinga España

03:21 AM

02:48 AM

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

02:48 AM

01:07 AM

TradingKey - TradingKey

01:07 AM

Jul 26, 2026

BioCryst Pharmaceuticals Inc - TradingKey

Jul 26, 2026

Jul 26, 2026

Rice Hall James & Associates LLC Acquires 325,959 Shares of BioCryst Pharmaceuticals, Inc. $BCRX - MarketBeat

Jul 26, 2026

Jul 26, 2026

BioCryst Pharmaceuticals Inc (BCRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026

Jul 25, 2026

Why Did BCRX Stock Surge Over 10% In After-Hours Trading Today? - Stocktwits

Jul 25, 2026

Jul 25, 2026

BioCryst Pharmaceuticals, Inc. Revenue Breakdown – MUN:BO1 - TradingView

Jul 25, 2026

Jul 24, 2026

BioCryst Pharmaceuticals (NASDAQ:BCRX) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Jul 24, 2026

Jul 24, 2026

BioCryst Pharmaceuticals Inc (BCRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026

Jul 23, 2026

Biocryst Pharmaceuticals Inc. (BCRX) Fundamental & Financial Data - Stocktwits

Jul 23, 2026

Jul 23, 2026

BCRX: Biocryst Pharmaceuticals Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Jul 23, 2026

Jul 23, 2026

BCRX Q2'26 Earnings: revenue estimate is 183.28M USD - TradingView

Jul 23, 2026

Jul 23, 2026

(BCRX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Jul 23, 2026

Jul 23, 2026

How Investors May Respond To BioCryst (BCRX) Hiring Its First CSO To Drive Rare-Disease Deals - simplywall.st

Jul 23, 2026

Jul 23, 2026

BCRX|BioCryst Pharmaceuticals Inc|Price:9.340|Chg%:-0.040 - TradingKey

Jul 23, 2026

Jul 22, 2026

BioCryst schedules a look at second-quarter results for Aug. 5 - Stock Titan

Jul 22, 2026

Jul 22, 2026

BioCryst to Report Second Quarter 2026 Financial Results on August 5 - The Manila Times

Jul 22, 2026

Jul 21, 2026

Can BioCryst Pharmaceuticals (BCRX) Be Worth More As A New CSO Sharpens Its Pipeline Story? - Sahm

Jul 21, 2026

Jul 21, 2026

BioCryst Pharmaceuticals (BCRX): Investor Outlook on a Biotech with 130% Potential Upside - DirectorsTalk Interviews

Jul 21, 2026

Jul 20, 2026

BioCryst Pharmaceuticals (BCRX) Proxy filing Summary - Quartr

Jul 20, 2026

Jul 18, 2026

BioCryst Pharmaceuticals (BCRX) Q4 2025 earnings summary - Quartr

Jul 18, 2026

Jul 17, 2026

Citizens reiterates BioCryst stock rating on Orladeyo revenue outlook By Investing.com - Investing.com Nigeria

Jul 17, 2026

Jul 17, 2026

BioCryst stock trades steadily as Orladeyo revenue supports rare disease focus - ad-hoc-news.de

Jul 17, 2026

Jul 17, 2026

Citizens reiterates BioCryst stock rating on Orladeyo revenue outlook - Investing.com

Jul 17, 2026

Jul 16, 2026

BioCryst Appoints David W. Jenkins as Chief Scientific Officer - Sahm

Jul 16, 2026

Jul 16, 2026

631,290 Shares in BioCryst Pharmaceuticals, Inc. $BCRX Purchased by IMC Chicago LLC - MarketBeat

Jul 16, 2026

Jul 15, 2026

BofA Securities Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Announces Target Price $15 - Moomoo

Jul 15, 2026

Jul 15, 2026

BioCryst Pharmaceuticals Names David W. Jenkins Chief Scientific Officer to Lead External Innovation Strategy - Quiver Quantitative

Jul 15, 2026

Jul 15, 2026

BioCryst names David Jenkins as chief scientific officer By Investing.com - Investing.com Canada

Jul 15, 2026

Jul 15, 2026

BioCryst’s New Science Chief Brings Over 20 Years in Biopharma - Stock Titan

Jul 15, 2026

Jul 14, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 14, 2026

Jul 14, 2026

Wall Street Analysts Think BioCryst (BCRX) Could Surge 117.96%: Read This Before Placing a Bet - Zacks Investment Research

Jul 14, 2026

Jul 14, 2026

BioCryst (BCRX) Stock Looks Like A Bargain After Facility Closure - Sahm

Jul 14, 2026

Jul 13, 2026

Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs? - Stocktwits

Jul 13, 2026

Jul 13, 2026

BCRX Reinstated by JP Morgan -- Price Target Announced at $12.00 - GuruFocus

Jul 13, 2026

Jul 13, 2026

BioCryst Pharmaceuticals (BCRX) Reshapes R And D As Fair Value Narrative Stays In Focus - Sahm

Jul 13, 2026

Jul 13, 2026

BioCryst (BCRX) Coverage Resumed by JPMorgan with Neutral Rating - GuruFocus

Jul 13, 2026

Jul 13, 2026

JPMorgan resumes BioCryst Pharma stock coverage with neutral rating - Investing.com

Jul 13, 2026

Jul 13, 2026

JPMorgan resumes BioCryst Pharma stock coverage with neutral rating By Investing.com - Investing.com Canada

Jul 13, 2026

Jul 13, 2026

BioCryst Pharmaceuticals (BCRX) Cantor Global Healthcare Conference 2025 Summary - Quartr

Jul 13, 2026

Jul 10, 2026

Is BioCryst (BCRX) Trading Internal Discovery for a More Durable Rare-Disease Innovation Model? - Sahm

Jul 10, 2026

Jul 09, 2026

BioCryst Pharmaceuticals Inc. (BCRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com

Jul 09, 2026

Jul 09, 2026

BioCryst (BCRX) Stock Looks Below Fair Value As Caution Lingers - Yahoo Finance

Jul 09, 2026

Jul 08, 2026

BioCryst Pharmaceuticals (BCRX) Ends Internal Discovery And Closes Birmingham Facility - Yahoo Finance

Jul 08, 2026

Jul 08, 2026

BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains? - Yahoo Finance

Jul 08, 2026

Jul 08, 2026

BioCryst Pharmaceuticals (BCRX) 2024 Cantor Fitzgerald Global Healthcare Conference summary - Quartr

Jul 08, 2026